Skip to main content
. 2017 Aug 6;8(40):66925–66939. doi: 10.18632/oncotarget.19963

Figure 6. Mitochondrial complex III and IV proteins are associated with poor clinical outcome in ovarian cancer patients.

Figure 6

A. Note that high levels of UQCRFS1 and UQCR7 predict significantly reduced overall survival. B. Similarly, high levels of COX6B and COX17 predict significantly reduced overall survival.